Compare Abeona Therapeutics Inc (ABEO) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Manchester United PLC — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Manchester United PLC trades at $22.23 (market cap $3.80B). The key difference: Manchester United PLC is far larger — about 9× Abeona Therapeutics Inc's market cap, and Manchester United PLC pays a 1.26% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | MANU | |
|---|---|---|
Market Cap | $421.19M | $3.80B |
Sector | Health | Media |
52-Week High | $7.45 | $23.53 |
52-Week Low | $4.17 | $15.10 |
Enterprise Value | $276.10M | $4.74B |
Dividend Yield | — | 1.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
